Anne-Marie Caminade

USPTO Granted Patents = 8 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 18(Granted Patents)

Location History:

Tolouse, FR (2010)
Toulouse, FR (2005 - 2018)

Company Filing History:

6 out of 5,072

Centre National De La Recherche Scientifique

Institut National De La Recherche Agronomique

patents

4. 1 out of 44

Aventis Cropscience S.a.

patents

5. 1 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

6. 1 out of 124

Université Paul Sabatier (toulouse Iii)

patents

7. 1 out of 111

Université De Rennes 1

where one patent can have more than one assignee

Years Active: 2005-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10106565 - Phosphorylated dendrimers as antiinflammatory drugs (2018-10-23),

2. 8535643 - Flourescent dendrimer compounds and use of such compounds in multi-photon devices or processes (2013-09-17),

3. 8039580 - Dendritic polymers having monophosphonic terminations, method for preparing them, and their use (2011-10-18),

4. 7838625 - Dendritic polymers having biphosphonic terminations, derivatives thereof, method for preparing them, and their use (2010-11-23),

5. 7658946 - Solid supports functionalized with phosphorus-containing dendrimers, process for preparing them and uses thereof (2010-02-09),

6. 7517538 - Solid supports functionalised with phosphorus dendrimers, method for preparing same and uses thereof (2009-04-14),

7. 6969528 - Phosphorus-containing dendrimers as transfection agents (2005-11-29),

8. 6939831 - Pestcide and/or plant growth regulating compositions (2005-09-06),

Title: Anne-Marie Caminade: Innovator in Dendritic Chemistry

Introduction

Anne-Marie Caminade is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of dendritic chemistry, particularly in the development of innovative compounds for medical applications. With a total of 8 patents, her work has garnered attention for its potential impact on treating inflammatory diseases.

Latest Patents

Caminade's latest patents include groundbreaking research on phosphorylated dendrimers as anti-inflammatory drugs. These dendrimers are designed with monophosphonic or bisphosphonic terminations, targeting the treatment of inflammatory diseases. Another notable patent involves fluorescent dendrimer compounds, which are utilized in multi-photon devices or processes. This chemical compound consists of an n-generation dendrimer that exhibits unique properties, including at least one central nucleus and two-photon absorption capabilities.

Career Highlights

Throughout her career, Anne-Marie Caminade has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Rhodia UK Limited. Her research has not only advanced the field of dendritic chemistry but has also opened new avenues for therapeutic applications.

Collaborations

Caminade has collaborated with notable scientists, including Jean-Pierre Majoral and Bernard Meunier. These partnerships have further enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Anne-Marie Caminade's contributions to dendritic chemistry and her innovative patents highlight her role as a leading inventor in the scientific community. Her work continues to inspire advancements in medical applications and demonstrates the importance of research in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.